Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve the Unaudited Standalone ....
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has informed stock exchanges that its Board of Directors will meet on Thursday, August 7, 2025, at the company's registered office in Ahmedabad. The main agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26). The company has also noted that the trading window for dealing in its securities has been closed from July 1, 2025, and will reopen 48 hours after the results are made public. Any other business items may be taken up with the Chairman's permission.
This is a routine regulatory filing ahead of the Q1 FY26 earnings announcement. Investors should watch for the actual results on August 7 for signals on revenue growth, margins, and profitability. No material action is expected from this notice alone.